These mirrored the effects of LY2109761 which is a TGF‐β receptor type‐I and type‐II dual inhibitor38 (Figure 4C,D), suggesting that PFD might suppress metastasis through disturbing TGF‐β‐induced EMT in breast cancer cells. This evidence concerns the gene TGFB1 and breast carcinoma.